首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1532524

PCR 技术市场 - 按产品、技术、应用、最终用途 - 全球预测

PCR Technologies Market - By Product, Technique, Application, End-use - Global Forecast

出版日期: 2024年05月22日 | 出版商:

Global Market Insights Inc. | 英文 207 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于法医和环境测试的广泛采用，2024 年至 2032 年全球 PCR 技术市场的复合年增长率将超过 8.1%。在法医学中，PCR 有助于分析刑事调查的遗传物质，提高证据收集和鑑定的准确性。在环境检测中，PCR用于检测土壤、水和空气中的污染物和污染物，提供精确、快速的结果。这种广泛的应用凸显了 PCR 技术在应对复杂挑战、推动持续投资和发展方面的多功能性。举个例子，2023年2月，Thermo Fisher Scientific在印度推出了Applied Biosystems TaqPath PCR试剂盒。这些试剂盒经过临床验证，由 Mylab Discovery Solutions 生产，支援 MTB MDR 和 HBV 等传染病的检测。

PCR 技术市场根据产品、技术、应用、最终用途和地区进行分组。

由于强调分子诊断的精确性和可靠性，到 2032 年，消耗品领域将呈现显着的复合年增长率。随着医疗保健系统专注于个人化医疗和早期疾病检测，对高品质耗材的需求正在激增。随着 PCR 检测中对准确结果和一致性能的追求，以及 PCR 技术应用范围的不断扩大，将刺激对耗材的需求，确保细分市场的成长。

在已建立的可靠性和成本效益技术的推动下，到 2032 年，传统 PCR 领域将占据显着的市场份额。由于其简单性和准确性，该技术仍然是常规遗传分析和研究的首选方法。随着越来越多的实验室和研究机构寻求可靠且经济实惠的 DNA 分析解决方案，对传统 PCR 的需求不断增长。 PCR 技术在教育和临床环境中的广泛采用支持了它的持久流行。

由于对基因功能和调控的详细了解的需求不断增加，基因表现分析领域将在预测期内表现出强劲的复合年增长率。研究人员和临床医生正致力于了解基因表现模式，以促进个人化医学和治疗的发展。由于基因表现研究是科学和医学进步不可或缺的一部分，因此对基于 PCR 的可靠技术来分析基因活性的需求激增。

由于强大的医疗基础设施和医学研究投资，北美 PCR 技术市场规模将在 2024 年至 2032 年期间显着扩大。该地区先进的医疗保健系统优先考虑精准诊断和个人化医疗。研究计划的资金增加，并且大力强调创新医疗技术的刺激。领先的生物技术公司和研究机构的存在加速了先进 PCR 技术在该地区的采用，促进了市场的成长。

产业生态系统分析
产业影响力
- 成长动力
  - 对分子诊断和 POCT 检测的需求不断增加
  - PCR 技术的进步
  - 传染病和遗传性疾病的盛行率不断增加
  - 增加研究和开发活动
- 产业陷阱与挑战
  - PCR设备成本高
  - 缺乏训练有素的专家
成长潜力分析
未来市场趋势
技术景观
差距分析
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
试剂盒和试剂
耗材
- PCR管
- PCR 微孔板
- 盖子/盖子
- 其他消耗品
仪器仪表
软体与服务

第 6 章：市场估计与预测：按技术分类，2021 - 2032 年

主要趋势
常规PCR
实时定量PCR
数位PCR
逆转录PCR
热启动PCR
多重PCR
其他技术

第 7 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
基因表现分析
基因定序
基因分型
核酸检测
核酸合成
标准验证/验证
诊断应用
其他应用

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院和诊断中心
研究与学术机构
製药和生物技术公司
其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Abbott Laboratories
Agilent Technologies, Inc.
bioMerieux S.A.
Bio-Rad Laboratories, Inc
Danaher Corporation
Eppendorf SE
F. Hoffmann-LA Roche Ltd.
Illumina, Inc.
Merck KGaA
New England Biolabs
Promega Corporation
QIAGEN N.V.
Standard Biotools Inc.
Takara Holdings Inc.
Thermo Fisher Scientific Inc.

简介目录

Product Code: 5551

Global PCR Technologies Market will showcase over 8.1% CAGR from 2024 to 2032, catapulted by the heightened adoption of forensic and environmental testing. In forensic science, PCR is instrumental in analyzing genetic material for criminal investigations, enhancing the accuracy of evidence collection and identification. In environmental testing, PCR is used to detect pollutants and contaminants in soil, water, and air, offering precise and rapid results. This broadened application highlights the versatility of PCR technologies in tackling complex challenges, driving continued investment and development. Quoting an instance, In February 2023, Thermo Fisher Scientific rolled out the Applied Biosystems TaqPath PCR kits in India. These kits validated for clinical use, were produced with Mylab Discovery Solutions, and support the detection of infectious diseases such as MTB MDR and HBV.

The PCR technologies market is grouped based on product, technique, application, end-use, and region.

The consumables segment will evince a remarkable CAGR through 2032, due to the emphasis on precision and reliability in molecular diagnostics. As healthcare systems focus on personalized medicine and early disease detection, the need for high-quality consumables is surging. With search for accurate results and consistent performance in PCR testing, alongside the expanding range of applications for PCR technologies will fuel the demand for consumables, ensuring segment growth.

The conventional PCR segment will grab a noteworthy market share by 2032, driven by the techniques established reliability and cost-effectiveness. This technique remains a preferred method for routine genetic analysis and research due to its simplicity and accuracy. As more laboratories and research institutions seek dependable and affordable solutions for DNA analysis, the demand for conventional PCR thrives. The widespread adoption of PCR technologies in educational and clinical settings supports its enduring popularity.

The gene expression analysis segment will exhibit a strong CAGR during the forecast period, owing to the elevating need for detailed insights into gene function and regulation. Researchers and clinicians are focusing on understanding gene expression patterns to advance personalized medicine and therapeutic development. As gene expression studies are integral to scientific and medical advancements, the requirement for reliable PCR-based techniques for analyzing gene activity catapults the demand.

North America PCR technologies market size will expand at a notable pace during 2024-2032, because of a robust healthcare infrastructure and investments in medical research. The regions advanced healthcare systems prioritize precision diagnostics and personalized medicine. There is increased funding for research initiatives and a strong emphasis on innovative medical technologies stimulate. The presence of leading biotechnology firms and research institutions accelerates the adoption of advanced PCR technologies in the region, bolstering the market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing demand for molecular diagnostics and POCT testing
  - 3.2.1.2 Advancement in PCR technologies
  - 3.2.1.3 Increasing prevalence of infectious diseases and genetic disorders
  - 3.2.1.4 Increasing research and development activities
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of PCR devices
  - 3.2.2.2 Dearth of trained experts
3.3 Growth potential analysis
3.4 Future market trends
3.5 Technological landscape
3.6 GAP analysis
3.7 Regulatory landscape
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Kits & reagents
5.3 Consumables
- 5.3.1 PCR tubes
- 5.3.2 PCR microplates
- 5.3.3 Cap/lids
- 5.3.4 Other consumables
5.4 Instruments
5.5 Software & services

Chapter 6 Market Estimates and Forecast, By Technique, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Conventional PCR
6.3 Real-time PCR
6.4 Digital PCR
6.5 Reverse transcription PCR
6.6 Hot-start PCR
6.7 Multiplex PCR
6.8 Other techniques

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Gene expression analysis
7.3 Genetic sequencing
7.4 Genotyping
7.5 Nucleic acid detection
7.6 Nucleic acid synthesis
7.7 Standard validation/ verification
7.8 Diagnostic application
7.9 Other applications

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals & diagnostic centers
8.3 Research & academics institutes
8.4 Pharma & biotech companies
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa